Monte Rosa Therapeutics, Inc. (GLUE) SEC Filings — 2024

Filings

• Monte Rosa Therapeutics Appoints New Director, Adjusts Executive Compensation — 8-K · Dec 13, 2024
• Monte Rosa Therapeutics Files 8-K — 8-K · Dec 5, 2024
• Monte Rosa Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Monte Rosa Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Monte Rosa Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
• Versant Venture Capital VI Amends Monte Rosa Therapeutics Stake — SC 13D/A · Oct 30, 2024
• Monte Rosa Therapeutics Files 8-K — 8-K · Oct 28, 2024
• Versant Venture Capital VI Amends Monte Rosa Therapeutics Stake — SC 13D/A · Sep 24, 2024
• Versant Venture Capital VI Amends Monte Rosa Therapeutics Stake — SC 13D/A · Aug 12, 2024
• NEA 17 Amends Monte Rosa Therapeutics Stake Filing — SC 13D/A · Aug 12, 2024
• Monte Rosa Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
• Monte Rosa Therapeutics Files 8-K — 8-K · Jun 27, 2024
• Monte Rosa Therapeutics Files 8-K on Security Holder Vote Matters — 8-K · Jun 12, 2024
• Monte Rosa Therapeutics Appoints New CMO, Directors — 8-K · May 30, 2024
• Monte Rosa Therapeutics Enters Material Definitive Agreement — 8-K · May 16, 2024
• NEA 17 Amends Monte Rosa Therapeutics 13D Filing — SC 13D/A · May 13, 2024
• Monte Rosa Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
• Monte Rosa Therapeutics Updates Executive Compensation — 8-K · May 2, 2024
• Monte Rosa Therapeutics Files Proxy Materials — DEFA14A · Apr 26, 2024
• Monte Rosa Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Apr 10, 2024
• Monte Rosa Therapeutics, Inc. Files 2023 Annual Report (10-K) — 10-K · Mar 14, 2024
• Monte Rosa Therapeutics, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
• Monte Rosa Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Monte Rosa Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Monte Rosa Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Monte Rosa Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• FMR LLC Discloses 11.056% Stake in Monte Rosa Therapeutics — SC 13G/A · Feb 9, 2024
• Monte Rosa Therapeutics Files Routine 8-K on Jan 8, 2024 — 8-K · Jan 8, 2024